Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

January 9, 2017January 9, 2017

Older Patients with Non-small Cell Lung Cancer Face Significant Challenges After Treatment, Study Shows

Lung Cancer, News

Older patients with early non-small cell lung cancer (NSCLC) can spend an average of one in three days interacting with the healthcare system during the initial 60 days after treatment — either ... Read more

December 22, 2016December 22, 2016

Chronic Shortness of Breath May Be Symptom of COPD or Heart Disease

COPD, News

Researchers from the University of Gothenburg’s Sahlgrenska Academy in Gothenburg, Sweden, studied the relationship between chronic shortness of breath and more serious health issues like heart failure or chronic obstructive pulmonary disease (COPD). ... Read more

December 20, 2016December 20, 2016

Wnt5A Protein Linked to Inability of Lungs to Repair COPD Damage

COPD, News

Researchers believe that a protein called Wnt5A may be the cause of why the lungs of patients with chronic obstructive pulmonary disease (COPD) lose the ability to repair themselves. The ... Read more

December 12, 2016December 12, 2016

Adults with Asthma Often Have Insomnia, Study Finds

Asthma, News

A new study reports that insomnia is highly prevalent in adults with asthma and is associated with adverse outcomes, including worse asthma control, symptoms of depression and anxiety, poorer quality ... Read more

December 8, 2016December 8, 2016

Study Links Menopause to Lung Function Decline in Women

News

Menopausal women experience a decline in lung function similar to smoking 20 cigarettes a day for a decade, according to new research from Norway. The study, “Menopause is Associated with ... Read more

December 6, 2016December 6, 2016

Positive Trial Results of Pulmaquin Reported for Non-CF Bronchiectasis Patients with Chronic Lung Infections

Bronchiectasis, News

Aradigm reported positive results from the ORBIT-3 (NCT01515007 ) and ORBIT-4 (NCT02104245) Phase 3 clinical trials assessing Pulmaquin for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE) in patients with chronic lung infection by Pseudomonas aeruginosa bacteria. The pivotal clinical trials ... Read more

December 2, 2016December 2, 2016

Galapagos Begins Phase 1 Trial of Cystic Fibrosis Corrector in Healthy Volunteers

Cystic Fibrosis, News

Belgium-based Galapagos NV has started its Phase 1 clinical trial evaluating its novel C2 corrector GLPG2737 in healthy volunteers. The drug was developed as part of a triple combination therapy for ... Read more

November 30, 2016November 30, 2016

Smartinhaler Use Helps Children with Severe Asthma Stay with Treatments, Study Finds

Asthma, News

Adherium Limited announced promising results from a clinical trial evaluating the use of Smartinhaler, its respiratory disease management tool, in children with poorly controlled asthma. Over 12 months, Smartinhaler use was seen to significantly reduce ... Read more

November 29, 2016November 29, 2016

Blood Test Seen to Predict Chemotherapy Response in Advanced Lung Cancer Patients

Lung Cancer, News

Scientists at the Cancer Research UK Manchester Institute found that a simple blood test may tell how well patients with small-cell lung cancer (SCLC) will respond to chemotherapy. The study, “Molecular analysis ... Read more

November 17, 2016November 17, 2016

Multidrug-Resistant Bacterium in Cystic Fibrosis Patients Spreading Globally, Study Finds

Cystic Fibrosis, News

A study led by England’s University of Cambridge and the Wellcome Trust Sanger Institute showed that multidrug-resistant nontuberculous mycobacterium, known to cause serious complications in cystic fibrosis (CF) patients, has spread globally ... Read more